Revolution Medicines, Inc. (RVMD) Dividend History

Revolution Medicines, Inc. (RVMD) is a biopharmaceutical company focused on developing targeted therapies for genetically driven cancers. The company specializes in designing innovative medicines aimed at specific genetic mutations involved in cancer progression, with an emphasis on solid tumors and hematologic malignancies.

700 Saginaw Dr, Redwood City, CA, 94063
Phone: 415-766-3638
Website: https://www.revmed.com

Dividend History

Revolution Medicines, Inc. currently does not pay dividends

Company News

Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines’ Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lung Cancer

Tango Therapeutics initiated a Phase 1/2 clinical trial combining TNG462 with Revolution Medicines' daraxonrasib or zoldonrasib to treat RAS-mutant MTAP-deleted pancreatic and lung cancers, targeting potential new precision cancer therapies.

GlobeNewswire Inc.

Featured Companies: TNGX
Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter - Benzinga

Three healthcare stocks, Aveanna Healthcare Holdings Inc, Revolution Medicines, and Fulcrum Therapeutics, have seen significant price gains recently, indicating they may be overbought and could pose risks to investors focused on momentum trading.

Benzinga

Featured Companies: AVAH FULC
Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates

Sage Therapeutics (SAGE) delivered earnings and revenue surprises of -10.43% and 28.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Featured Companies: SAGE
Why Revolution Medicines Stock Is Crashing Today

Investors were disappointed by Revolution Medicines' data, presented at ESMO.

The Motley Fool

Page data last updated 07/23/2025 11:58:50 UTC